Topical and systemic therapies for oral and perioral herpes simplex virus infections.
Eric T Stoopler, Ramesh Balasubramaniam
Index: J. Calif. Dent. Assoc. 41(4) , 259-62, (2013)
Full Text: HTML
Abstract
Oral and perioral herpes simplex virus (HSV) infections in healthy individuals often present with signs and symptoms that are clearly recognized by oral health care providers (OHCPs). Management of these infections is dependent upon a variety of factors and several agents may be used for treatment to accelerate healing and decrease symptoms associated with lesions. This article will review the pertinent aspects of topical and systemic therapies of HSV infections for the OHCP.
Related Compounds
Related Articles:
2015-01-01
[Nucleic Acids Res. 43(1) , 493-503, (2015)]
2011-01-01
[Mol. Cancer 10 , 20, (2011)]
2015-06-08
[ChemPhysChem 16 , 1627-34, (2015)]
2014-07-01
[Anticancer Res. 34(7) , 3557-62, (2014)]
2012-01-01
[Molecules 17(8) , 8735-41, (2012)]